Amanote Research

Amanote Research

    RegisterSign In

The Distribution of Sales Revenues From Pharmaceutical Innovation

PharmacoEconomics - United Kingdom
doi 10.2165/00019053-200018001-00005
Full Text
Open PDF
Abstract

Available in full text

Categories
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
Date

January 1, 2000

Authors
Henry G. GrabowskiJohn Vernon
Publisher

Springer Nature


Related search

Maximization of Revenues for Power Sales From a Solid Waste Resources Recovery Facility

1991English

Innovation in the Pharmaceutical Industry

BMJ
1978English

Innovation in the Pharmaceutical Industry

Journal of the Royal Society of Medicine
Medicine
2000English

Cost of Innovation in the Pharmaceutical Industry

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
1991English

A Pioneer Sales Organization in the Japanese Pharmaceutical Industry:

Keiei Shigaku (Japan Business History Review)
2008English

Editorial: Journal of Pharmaceutical Innovation 2.0

Journal of Pharmaceutical Innovation
Drug DiscoveryPharmaceutical Science
2020English

Pharmaceutical Innovation and Parallel Trade

International Journal of Industrial Organization
Industrial RelationsIndustrialFinanceEconomicsManufacturing EngineeringStrategyManagementEconometricsAerospace Engineering
2014English

The Generic Pharmaceutical Industry: Moving Beyond Incremental Innovation Towards Re-Innovation

GaBI Journal
Drug GuidesPharmacy
2013English

The Use of Revenues From Carbon Pricing

OECD Taxation Working Papers
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy